Mannatech Return on Tangible Equity 2010-2025 | MTEX

Current and historical return on tangible equity values for Mannatech (MTEX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Mannatech Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.00B $0.01B -11.43%
2024-12-31 $0.00B $0.01B 21.62%
2024-09-30 $0.00B $0.01B -21.05%
2024-06-30 $0.00B $0.01B -20.51%
2024-03-31 $0.00B $0.01B -18.60%
2023-12-31 $0.00B $0.01B -17.02%
2023-09-30 $-0.01B $0.01B -54.90%
2023-06-30 $-0.01B $0.01B -40.68%
2023-03-31 $0.00B $0.01B -23.53%
2022-12-31 $-0.01B $0.01B -25.64%
2022-09-30 $0.01B $0.02B 22.73%
2022-06-30 $0.01B $0.02B 29.79%
2022-03-31 $0.01B $0.02B 32.99%
2021-12-31 $0.01B $0.02B 40.40%
2021-09-30 $0.01B $0.03B 31.68%
2021-06-30 $0.01B $0.02B 27.45%
2021-03-31 $0.01B $0.03B 23.30%
2020-12-31 $0.01B $0.03B 26.67%
2020-09-30 $0.01B $0.03B 30.19%
2020-06-30 $0.01B $0.03B 19.05%
2020-03-31 $0.01B $0.03B 22.43%
2019-12-31 $0.00B $0.03B 15.24%
2019-09-30 $0.00B $0.03B 0.00%
2019-06-30 $0.00B $0.03B -3.77%
2019-03-31 $0.00B $0.03B -10.91%
2018-12-31 $0.00B $0.03B -12.90%
2018-09-30 $-0.01B $0.03B -17.27%
2018-06-30 $0.00B $0.03B -7.84%
2018-03-31 $0.00B $0.04B -2.45%
2017-12-31 $0.00B $0.04B -4.91%
2017-09-30 $0.00B $0.04B 2.47%
2017-06-30 $0.00B $0.04B 2.47%
2017-03-31 $0.00B $0.04B -4.97%
2016-12-31 $0.00B $0.04B 0.00%
2016-09-30 $0.00B $0.04B 7.45%
2016-06-30 $0.00B $0.04B 5.13%
2016-03-31 $0.01B $0.04B 15.79%
2015-12-31 $0.01B $0.04B 16.55%
2015-09-30 $0.01B $0.04B 17.52%
2015-06-30 $0.01B $0.04B 34.11%
2015-03-31 $0.01B $0.03B 23.93%
2014-12-31 $0.01B $0.03B 22.22%
2014-09-30 $0.01B $0.03B 28.00%
2014-06-30 $0.00B $0.02B 4.35%
2014-03-31 $0.00B $0.02B 13.48%
2013-12-31 $0.00B $0.02B 18.82%
2013-09-30 $0.00B $0.02B 4.88%
2013-06-30 $0.00B $0.02B 19.75%
2013-03-31 $0.00B $0.02B 5.13%
2012-12-31 $0.00B $0.02B -5.19%
2012-09-30 $-0.01B $0.02B -40.51%
2012-06-30 $-0.01B $0.02B -64.37%
2012-03-31 $-0.02B $0.02B -68.00%
2011-12-31 $-0.02B $0.02B -71.79%
2011-09-30 $-0.02B $0.03B -50.00%
2011-06-30 $-0.01B $0.03B -36.84%
2011-03-31 $-0.01B $0.04B -31.33%
2010-12-31 $-0.01B $0.04B -24.58%
2010-09-30 $-0.01B $0.04B -12.70%
2010-06-30 $-0.01B $0.05B -28.87%
2010-03-31 $-0.02B $0.05B -30.92%
2009-12-31 $-0.02B $0.05B -32.58%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.014B $0.118B
Mannatech Inc is a wellness solution provider that sells its products through a global network-marketing system throughout the United States and the international markets of Canada, Australia, the United Kingdom, Japan and New Zealand.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $65.985B 25.38
Zoetis (ZTS) United States $65.698B 23.83
Daiichi Sankyo, - (DSNKY) Japan $46.506B 23.83
Takeda Pharmaceutical (TAK) Japan $45.692B 9.32
BeOne Medicines - (ONC) Cayman Islands $32.693B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.460B 0.00
Summit Therapeutics (SMMT) United States $20.847B 0.00
Merck (MKKGY) Germany $15.858B 10.31
Shionogi (SGIOY) Japan $15.060B 15.09
United Therapeutics (UTHR) United States $13.506B 11.69
Neurocrine Biosciences (NBIX) United States $12.457B 37.16
IPSEN (IPSEY) France $10.420B 0.00
Orion OYJ (ORINY) Finland $10.275B 24.76
Madrigal Pharmaceuticals (MDGL) United States $7.600B 0.00
Corcept Therapeutics (CORT) United States $7.532B 63.26
Stevanato Group S.p.A (STVN) Italy $7.329B 43.21
Grifols, S.A (GRFS) Spain $7.322B 0.00
Ionis Pharmaceuticals (IONS) United States $6.543B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 17.90
Soleno Therapeutics (SLNO) United States $4.183B 0.00
Hypermarcas (HYPMY) Brazil $2.673B 20.09
Crinetics Pharmaceuticals (CRNX) United States $2.610B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.578B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.573B 12.25
Catalyst Pharmaceuticals (CPRX) United States $2.395B 8.05
Centessa Pharmaceuticals (CNTA) United Kingdom $2.296B 0.00
Ocular Therapeutix (OCUL) United States $2.140B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.753B 0.00
ARS Pharmaceuticals (SPRY) United States $1.733B 0.00
Dyne Therapeutics (DYN) United States $1.592B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.505B 22.41
Evotec AG (EVO) Germany $1.371B 0.00
Guardian Pharmacy Services (GRDN) United States $1.296B 0.00
Ardelyx (ARDX) United States $1.239B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.232B 0.00
Harrow (HROW) United States $1.218B 0.00
Collegium Pharmaceutical (COLL) United States $1.058B 5.67
Xeris Biopharma Holdings (XERS) United States $1.032B 0.00
Enliven Therapeutics (ELVN) United States $0.878B 0.00
Cronos Group (CRON) Canada $0.871B 0.00
Akebia Therapeutics (AKBA) United States $0.791B 0.00
ProKidney (PROK) United States $0.751B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.699B 0.00
Zevra Therapeutics (ZVRA) United States $0.663B 0.00
KalVista Pharmaceuticals (KALV) United States $0.632B 0.00
Siga Technologies (SIGA) United States $0.612B 7.57
Elite Pharmaceuticals (ELTP) United States $0.605B 0.00
Relay Therapeutics (RLAY) United States $0.598B 0.00
Organogenesis (ORGO) United States $0.573B 0.00
Bioventus (BVS) United States $0.569B 13.86
Theravance Biopharma (TBPH) United States $0.561B 0.00
Tourmaline Bio (TRML) United States $0.548B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.546B 5.63
USANA Health Sciences (USNA) United States $0.530B 10.86
Xencor (XNCR) United States $0.522B 0.00
Oruka Therapeutics (ORKA) United States $0.512B 0.00
Savara (SVRA) United States $0.455B 0.00
Aquestive Therapeutics (AQST) United States $0.390B 0.00
Esperion Therapeutics (ESPR) United States $0.359B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.345B 0.00
Nanobiotix S.A (NBTX) France $0.339B 0.00
Aldeyra Therapeutics (ALDX) United States $0.310B 0.00
Larimar Therapeutics (LRMR) United States $0.303B 0.00
AleAnna (ANNA) United States $0.299B 0.00
Altimmune (ALT) United States $0.286B 0.00
Heron Therapeutics (HRTX) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.271B 17.64
Nektar Therapeutics (NKTR) United States $0.270B 0.00
4D Molecular Therapeutics (FDMT) United States $0.268B 0.00
Galectin Therapeutics (GALT) United States $0.243B 0.00
OmniAb (OABI) United States $0.230B 0.00
MediWound (MDWD) Israel $0.203B 0.00
China SXT Pharmaceuticals (SXTC) China $0.183B 0.00
Lyell Immunopharma (LYEL) United States $0.175B 0.00
Profound Medical (PROF) Canada $0.170B 0.00
Journey Medical (DERM) United States $0.170B 0.00
Aclaris Therapeutics (ACRS) United States $0.170B 0.00
MEI Pharma (MEIP) United States $0.165B 0.00
Korro Bio (KRRO) United States $0.149B 0.00
Lexeo Therapeutics (LXEO) United States $0.148B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.142B 22.00
Avita Medical (RCEL) United States $0.142B 0.00
Liminatus Pharma (LIMN) United States $0.126B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Inhibikase Therapeutics (IKT) United States $0.115B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.110B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.106B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Avalo Therapeutics (AVTX) United States $0.090B 0.00
VAXART, INC (VXRT) United States $0.089B 0.00
Cardiol Therapeutics (CRDL) Canada $0.089B 0.00
ESSA Pharma (EPIX) Canada $0.084B 0.00
Champions Oncology (CSBR) United States $0.084B 19.09
Dominari Holdings (DOMH) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
BioNxt Solutions (BNXTF) Canada $0.081B 0.00
Vivani Medical (VANI) United States $0.081B 0.00
Nutriband (NTRB) United States $0.080B 0.00
Surrozen (SRZN) United States $0.077B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Metagenomi (MGX) United States $0.072B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Inotiv (NOTV) United States $0.067B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Wellgistics Health (WGRX) United States $0.057B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
Unicycive Therapeutics (UNCY) United States $0.051B 0.00
PolyPid (PYPD) Israel $0.051B 0.00
Telomir Pharmaceuticals (TELO) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.82
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Fractyl Health (GUTS) United States $0.048B 0.00
Plus Therapeutics (PSTV) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
Klotho Neurosciences (KLTO) United States $0.043B 0.00
NRx Pharmaceuticals (NRXP) United States $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Scienture Holdings (SCNX) United States $0.036B 0.00
Karyopharm Therapeutics (KPTI) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Cosmos Health (COSM) United States $0.030B 0.00
Mural Oncology (MURA) Ireland $0.029B 0.00
Vivos Therapeutics (VVOS) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
Incannex Healthcare (IXHL) Australia $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
BioVie (BIVI) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 12.39
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.19
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00